Kennedy Capital Management’s Design Therapeutics DSGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$50.6K	Buy	15,010 +627	+4%	+$2.11K	﹤0.01%	581
2025 Q1	$55.5K	Buy	14,383 +117	+0.8%	+$452	﹤0.01%	642
2024 Q4	$88K	Buy	+14,266	New	+$88K	﹤0.01%	669